To combat escalating R&D costs, high clinical attrition and stringent global pricing pressures, the biopharmaceutical industry is on a quest to find the best...

The need for speed in clinical trials is becoming a strategic imperative for sponsors, with looming patent cliffs, rising R&D investment, increasing innovati...

Antibody-Drug Conjugates (ADCs) represent one of the most advanced classes of targeted therapies inoncology, combining the specificity of monoclonal antibodies w...

Tangential flow filtration (TFF) is a standard unit operation for concentration, buffer exchange and formulation across biopharmaceutical manufacturing. Process ...

Biologic therapies are reshaping the pharmaceutical landscape. Their growing complexity is creating new challenges for combination product development and delive...